MS patients show large differences between vascular age and chronological age, even if they don't have cardiovascular disease ...

Men with MS who started on high-efficacy DMTs had fewer relapses than those who started with moderate-efficacy DMTs, a U.S.

Immutep said IMP761 was found safe in initial data from a Phase 1 trial, with no treatment-related adverse events reported.

A rising incidence of MS diagnosed among older adults in a Sicilian province has been evident since 2005, particularly for ...

Columnist Desiree Lama, a lifelong Texan, struggles with the region's extreme heat, which can cause her MS symptoms to flare ...

About four in five adults with long-term stable MS who stopped first-line treatment with a DMT showed signs of disease ...

Columnist Desiree Lama has been living with MS for several years, yet she still appreciatea the advice and advocacy of her ...

Tolebrutinib, expected to soon be submitted for U.S. approval for nonrelapsing SPMS, was granted the FDA's breakthrough ...

Exercise effectively eases fatigue and improves muscular fitness in MS patients, but the best type differs for each outcome, ...

Columnist Ahna Crum knows what MS has taken from her, but she also recognizes the significant gifts it's granted over the ...

Columnist Ben Hofmeister offers a tongue-in-cheek collective nouns list for multiple sclerosis, its symptoms, and other things.

Columnist Ben Hofmeister recognizes how he doesn't want to lose control, even as he's learning to part with it willingly.